Renaissance Technologies
EVLO

Renaissance Technologies’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Renaissance Technologies’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,434
Closed -$151K – 3815
2020
Q3 		$151K Sell
1,434
-365
-20% -$33.3K ﹤0.01% 3160
2020
Q2 		$176K Buy
1,799
+420
+30% +$36.8K ﹤0.01% 3189
2020
Q1 		$104K Sell
1,379
-81
-6% -$7.71K ﹤0.01% 3222
2019
Q4 		$119K Buy
1,460
+735
+101% +$82.2K ﹤0.01% 3291
2019
Q3 		$88K Buy
+725
New +$99.7K ﹤0.01% 3272

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return